accuray inc - ARAY

ARAY

Close Chg Chg %
0.84 0.03 3.52%

Open Market

0.87

+0.03 (3.52%)

Volume: 504.21K

Last Updated:

Jan 15, 2026, 3:40 PM EDT

Company Overview: accuray inc - ARAY

ARAY Key Data

Open

$0.84

Day Range

0.83 - 0.88

52 Week Range

0.78 - 2.95

Market Cap

$95.21M

Shares Outstanding

113.34M

Public Float

107.88M

Beta

1.11

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.16

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

958.23K

 

ARAY Performance

1 Week
 
-4.90%
 
1 Month
 
-7.34%
 
3 Months
 
-50.24%
 
1 Year
 
-62.46%
 
5 Years
 
-82.30%
 

ARAY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About accuray inc - ARAY

Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. It develops, manufactures, sells, and supports medical solutions. The company was founded by John R. Adler in 1990 and is headquartered in Madison, WI.

ARAY At a Glance

Accuray, Inc.
1240 Deming Way
Madison, Wisconsin 53717-1954
Phone 1-608-824-2800 Revenue 458.51M
Industry Medical Specialties Net Income -1,591,000.00
Sector Health Technology 2025 Sales Growth 2.677%
Fiscal Year-end 06 / 2026 Employees 990
View SEC Filings

ARAY Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.307
Price to Book Ratio 1.901
Price to Cash Flow Ratio 49.23
Enterprise Value to EBITDA 18.527
Enterprise Value to Sales 0.565
Total Debt to Enterprise Value 0.681

ARAY Efficiency

Revenue/Employee 463,136.364
Income Per Employee -1,607.071
Receivables Turnover 4.671
Total Asset Turnover 0.977

ARAY Liquidity

Current Ratio 1.629
Quick Ratio 0.897
Cash Ratio 0.301

ARAY Profitability

Gross Margin 32.054
Operating Margin 1.71
Pretax Margin 0.247
Net Margin -0.347
Return on Assets -0.339
Return on Equity -2.52
Return on Total Capital -0.618
Return on Invested Capital -0.664

ARAY Capital Structure

Total Debt to Total Equity 217.296
Total Debt to Total Capital 68.484
Total Debt to Total Assets 37.508
Long-Term Debt to Equity 192.522
Long-Term Debt to Total Capital 60.676
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Accuray Inc - ARAY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
429.91M 447.61M 446.55M 458.50M
Sales Growth
+8.48% +4.12% -0.24% +2.68%
Cost of Goods Sold (COGS) incl D&A
269.95M 293.64M 303.43M 311.54M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.51M 4.53M 5.91M 6.15M
Depreciation
5.41M 4.33M 5.71M 6.10M
Amortization of Intangibles
100.00K 200.00K 200.00K 50.00K
COGS Growth
+14.01% +8.78% +3.33% +2.67%
Gross Income
159.96M 153.96M 143.12M 146.97M
Gross Income Growth
+0.28% -3.75% -7.04% +2.69%
Gross Profit Margin
+37.21% +34.40% +32.05% +32.05%
2022 2023 2024 2025 5-year trend
SG&A Expense
151.81M 148.88M 140.02M 139.13M
Research & Development
57.75M 57.13M 48.03M 47.94M
Other SG&A
94.06M 91.75M 91.98M 91.19M
SGA Growth
+10.59% -1.93% -5.95% -0.63%
Other Operating Expense
- - - -
-
Unusual Expense
2.04M 819.00K 3.21M 1.40M
EBIT after Unusual Expense
6.10M 4.26M (109.00K) 6.44M
Non Operating Income/Expense
24.00K (419.00K) (87.00K) 7.65M
Non-Operating Interest Income
- - - 1.19M
-
Equity in Earnings of Affiliates
241.00K 2.57M 1.84M 4.71M
Interest Expense
8.13M 10.63M 11.62M 12.95M
Interest Expense Growth
-51.88% +30.79% +9.33% +11.44%
Gross Interest Expense
8.13M 10.63M 11.62M 12.95M
Interest Capitalized
- - - -
-
Pretax Income
(2.00M) (6.79M) (11.82M) 1.13M
Pretax Income Growth
+56.09% -239.06% -74.13% +109.59%
Pretax Margin
-0.47% -1.52% -2.65% +0.25%
Income Tax
3.35M 2.49M 3.73M 2.73M
Income Tax - Current - Domestic
- 25.00K 133.00K 4.00K
Income Tax - Current - Foreign
1.53M 2.04M 2.19M 2.56M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
1.78M 456.00K 1.40M 156.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
241.00K 2.57M 1.84M 4.71M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(5.35M) (9.28M) (15.54M) (1.59M)
Minority Interest Expense
- - - -
-
Net Income
(5.35M) (9.28M) (15.54M) (1.59M)
Net Income Growth
+15.27% -73.56% -67.51% +89.77%
Net Margin Growth
-1.24% -2.07% -3.48% -0.35%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(5.35M) (9.28M) (15.54M) (1.59M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(5.35M) (9.28M) (15.54M) (1.59M)
EPS (Basic)
-0.0581 -0.0978 -0.1582 -0.0155
EPS (Basic) Growth
+15.31% -68.33% -61.76% +90.20%
Basic Shares Outstanding
92.09M 94.88M 98.27M 102.77M
EPS (Diluted)
-0.0581 -0.0978 -0.1582 -0.0155
EPS (Diluted) Growth
+15.31% -68.33% -61.76% +90.20%
Diluted Shares Outstanding
92.09M 94.88M 98.27M 102.77M
EBITDA
13.66M 9.61M 9.01M 13.99M
EBITDA Growth
-52.27% -29.66% -6.24% +55.28%
EBITDA Margin
+3.18% +2.15% +2.02% +3.05%

Snapshot

Average Recommendation BUY Average Target Price 4.25
Number of Ratings 2 Current Quarters Estimate -0.021
FY Report Date 03 / 2026 Current Year's Estimate -0.251
Last Quarter’s Earnings -0.108 Median PE on CY Estimate N/A
Year Ago Earnings -0.02 Next Fiscal Year Estimate -0.025
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate -0.02 0.06 -0.25 -0.03
High Estimates -0.02 0.06 -0.25 -0.03
Low Estimate -0.02 0.06 -0.25 -0.03
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Accuray Inc in the News